PHAXIAM Therapeutics S.A. - stock earnings
Stock symbol ERYP is outdated, potentially delisted? Maybe it is available on other exchange?
ERYP Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022Q3 | -5.1 million USD | 470000 USD |
| 2022Q2 | 10.9 million USD | 414000 USD |
| 2022Q1 | -11.9 million USD | 539000 USD |
| 2021Q4 | -12.9 million EUR | 955000 EUR |
| 2021Q3 | -13.6 million USD | 1.1 million USD |
| 2021Q2 | -16.0 million EUR | 830000 EUR |
| 2021Q1 | -11.9 million EUR | 1.4 million EUR |
| 2020Q4 | -19.7 million EUR | 828000 EUR |
| 2020Q3 | -18.6 million EUR | 1.0 million EUR |
| 2020Q1 | -17.6 million EUR | 747000 EUR |
ERYP Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2021 | -53.8 million USD | 4.2 million USD |
| 2020 | -73.3 million USD | 3.7 million USD |
| 2019 | -62.7 million USD | 5.3 million USD |
| 2018 | -38.2 million USD | 4.4 million USD |
| 2017 | -33.5 million EUR | 3.4 million EUR |
ERYP
Price: $0.78
52 week price:
Earnings Per Share: -2.80 USD
P/E Ratio: -1.86
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 11026
Market Capitalization: 23.9 million